Environmental, Social & Governance Report

Overview

The report describes Cutia Therapeutics' 2025 ESG governance, operational, environmental, and social performance. It highlights Board-led ESG oversight, a 7% reduction target for greenhouse gas emission intensity by 2030, and the first disclosure of Scope 3 emissions. The Group reported 304 employees, a 33% proportion of female Directors on the Board, and zero work-related fatalities. The report also details energy-efficiency measures, water recycling, supplier ESG assessments, and product-quality controls.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2025
Period: 1 January 2025 – 31 December 2025
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services